TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study

Recent advances in the development of chemotherapies have helped improve the prognosis of pancreatic ductal adenocarcinoma (PDAC). However, predicting factors for the outcomes of chemotherapies (either gemcitabine or S-1) have not yet been established. We analyzed the expression of 4 major epithelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Sho, Saiki, Yuriko, Fukushige, Shinichi, Yamanaka, Mie, Ishida, Masaharu, Motoi, Fuyuhiko, Unno, Michiaki, Horii, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110717/
https://www.ncbi.nlm.nih.gov/pubmed/36764935
http://dx.doi.org/10.1007/s00595-023-02655-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110717/
https://www.ncbi.nlm.nih.gov/pubmed/36764935
http://dx.doi.org/10.1007/s00595-023-02655-3

Ejemplares similares